Safety of Roxadustat Combined with Epoetin Alfa in Hemodialysis Patients with Anemia: A Cohort Study
Y Lu, X Liu, J Wang - 2022 - researchsquare.com
Background: Roxadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor that
stimulates erythropoiesis 1, China was the first country in the world to complete phase III …
stimulates erythropoiesis 1, China was the first country in the world to complete phase III …
[HTML][HTML] Diagnosis, management of chronic kidney disease and therapy of anemia associated with CKD
AL Vertkin, EA Prokhorovich, GY Knorring - Therapy, 2022 - bulletin.ssaa.ru
Numerous international studies have confirmed that chronic kidney disease (CKD) occurs as
often as the most socially significant cardiovascular diseases, diabetes mellitus, and obesity …
often as the most socially significant cardiovascular diseases, diabetes mellitus, and obesity …
[PDF][PDF] Anemia of chronic conditions: prevalence, clinical aspects and laboratory.
AA Zambrano Cedeño, YS Perero Cobeña… - scholar.archive.org
The anemia of chronic disease, also known as anemia of inflammation, is usually moderate
and characteristically presents with low serum iron and high ferritin. It is the most frequent …
and characteristically presents with low serum iron and high ferritin. It is the most frequent …
[PDF][PDF] Short-term impact of switching from erythropoiesis-stimulating agents and roxadustat to daprodustat among patients undergoing hemodialysis
K Iseri, M Mizobuchi, S Aoki, R Kuroiwa, N Terado… - 2022 - scholar.archive.org
Daprodustat is a novel oral agent for renal anemia. This retrospective study examined 124
maintenance patients undergoing HD who had shifted from erythropoiesis-stimulating …
maintenance patients undergoing HD who had shifted from erythropoiesis-stimulating …
# 2875 CONGESTION PHENOTYPES AND DECONGESTION PATTERNS ASSESSED BY POCUS IN HAEMODIALYSIS PATIENTS: A PILOT STUDY
GA Romero-González, M Lanau, J Soler… - Nephrology Dialysis …, 2023 - academic.oup.com
Abstract Background and Aims Despite the evolution of hemodialysis (HD) in recent years,
cardiovascular diseases continue to be the main cause of death in this group of patients …
cardiovascular diseases continue to be the main cause of death in this group of patients …
[PDF][PDF] GASTROINTESTINAL SYMPTOMS IN PATIENTS RECEIVING HEMODIALYSIS: PREVALENCE, SEVERITY AND ASSOCIATED FACTORS
J Khalmukhamedov - academia.edu
Results: Cholecalciferol significantly increased serum levels of 25 (OH) D in both groups. A
significant decrease in serum hsCRP levels (p< 0.001) and NLR was noted only in Group A …
significant decrease in serum hsCRP levels (p< 0.001) and NLR was noted only in Group A …
# 4287 GASTROINTESTINAL SYMPTOMS IN PATIENTS RECEIVING HEMODIALYSIS: PREVALENCE, SEVERITY AND ASSOCIATED FACTORS
J Trbojevic-Stankovic, G Kovačević… - Nephrology Dialysis …, 2023 - academic.oup.com
Abstract Background and Aims Gastrointestinal (GI) symptoms are common among patients
with chronic renal failure, especially in those treated with maintenance hemodialysis (HD) …
with chronic renal failure, especially in those treated with maintenance hemodialysis (HD) …
# 5742 MID-ARM CIRCUMFERENCE AS A CORRELATE TO DIFFERENT: ASPECT NEUROCOGNITIVE IMPAIRMENT IN HEMODIALYSIS PATIENTS
E Samaan, B Ayman, A Shams… - Nephrology Dialysis …, 2023 - academic.oup.com
Abstract Background and Aims Malnutrition is associated with poor cognitive function (CI) in
Hemodialysis (HD) patients. Both have multiple ways of assessment scaled from simple …
Hemodialysis (HD) patients. Both have multiple ways of assessment scaled from simple …